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This study aims to explore patients’ and therapists’ attitudes about the psychological
treatment they received (patients) or applied (therapists). The treatments were standard
CBT protocols for post-traumatic stress disorder (PTSD), complicated grief (CG), or
adjustment disorders (ADs), depending on each patient diagnosis. The treatments were
delivered following a traditional format or supported by a virtual reality (VR) system
“EMMA’s WORLD” designed for the treatment of stress-related disorders. “EMMA’s
WORLD” is a VR application in which patients can explore negative experiences using
different virtual elements that can be customized to make them more meaningful to the
user. The sample was composed of two groups: the “professionals” (N = 10) were
all clinical psychologists who applied the same psychological treatment in both the
traditional format (“traditional condition”) and using the VR system (“EMMA” condition).
The second group consisted of a sample of patients (N = 50) who met the criteria
for at least one of three different diagnoses: PTSD (N = 15), CG (N = 15), or AD
(N = 20). 25 patients received treatment in the traditional format and 25 supported
by the VR system. The patients were asked about their expectations (before treatment)
and satisfaction (after treatment) with the treatment they received. All the therapists were
asked their opinions about both treatment conditions. A mixed-methods approach using
quantitative and qualitative methodologies was used. In both conditions, high scores
were observed, and the patient’s opinions were even better when they have already
received the treatments. A more pronounced pre-test–post-test change in the EMMA
therapy group than in the traditional group was observed. EMMA’s World was well-
accepted by both patients and therapists, and it helped to foster motivation in patients,
while helping the therapist to apply the treatment. Thus, VR can be useful as an adjunct
tool to enhance the treatment.
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INTRODUCTION
In the DSM-5, disorders that are precipitated by specific
stressful and potentially traumatic events are included in a
new diagnostic category, “trauma and stressor-related disorders”
(SRDs) (American Psychiatric Association [APA], 2013). These
disorders occur when the person is not able to cope with
traumatic events or stressful situations and, consequently
develops a series of clinical symptoms that can significantly
affect his or her life. SRDs include several disorders and from
a clinical point of view, it is useful to group these disorders
together in order to distinguish, between different degrees
of psychopathological severity, ranging from normal (non-
pathological) distress, through clinical acute elevated stress, as
in adjustment disorders (ADs), to more serious and severe
psychopathology, as in post-traumatic stress disorder (PTSD)
(Friedman et al., 2011).
Fortunately, we now have excellent evidence based
psychological treatment strategies that have shown their
effectiveness. In vivo exposure therapy is considered one of
the most effective treatments for many psychological disorders
including SRD (Barlow et al., 2015). A significant empirical
base supports the efficacy of in vivo exposure, and data from
meta-analyses consistently show its usefulness (Deacon and
Abramowitz, 2004). Cognitive Behavior Therapy programs
that include exposure-based techniques have been shown to
be effective for the treatment of SRDs (Najavits and Anderson,
2015). Without a doubt, exposure therapy can be considered
one of the great success stories within the field of mental
health (Olatunji et al., 2009). Nevertheless, exposure therapy is
under-utilized in clinical settings (Becker et al., 2004). The data
indicate that, when they realize that the exposure involves direct
confrontation with the feared object or context, approximately
25% of patients reject or abandon it after starting (Marks and
O’Sullivan, 1992; Choy et al., 2007; García-Palacios et al., 2007;
Ong et al., 2016) because it is too aversive for them. Likewise,
many therapists have difficulties or feel reluctant when using
exposure with their patients because it might lead to a worsening
of patients’ symptoms or treatment rejection (Feeny et al., 2003;
Becker et al., 2004; Richard and Gloster, 2007; Deacon et al.,
2012). For example, Becker et al. (2004) found that in a sample
of 852 well-trained psychologists, only 17% of the clinicians
used exposure to treat PTSD. Along the same lines, Richard
and Gloster (2007) surveyed clinicians and found that exposure
is considered a quite aversive treatment. All this indicates that
some professionals maintain a negative view of this technique
(Olatunji et al., 2009).
Virtual reality (VR) can contribute to improving the clinical
utility of exposure therapy, by making it more easily accepted
(Botella et al., 1998). VR refers to the three-dimensional digital
worlds where the person can navigate and interact in real time,
even though these worlds only exist in the memory of the
computer. In the first case study conducted, VR was used with
an acrophobic patient to apply virtual exposure to her feared
situations (Rothbaum et al., 1995). This pioneering work raised
expectations about the utility of this technology in employing
the exposure technique. Basically, the exposure is designed in
such a way that the patient gradually and systematically faces the
situations, objects, or activities that he/she fears and avoids.
The new VR generation offers new opportunities for the
presentation of stimuli and contexts in ways that are impossible
in traditional in vivo exposure therapy (Lindner et al., 2017).
In the past 15 years, the use of VR as an exposure technique
has increased in terms of the number of problems it addresses
and their complexity, and review studies and meta-analyses have
been published on this topic (Powers and Emmelkamp, 2008;
Gerardi et al., 2010; Meyerbröker and Emmelkamp, 2010; Opris
et al., 2012; McCann et al., 2014; Turner and Casey, 2014;
Botella et al., 2015, 2017; Morina et al., 2015). The results of
all these studies show that VR is a valuable tool that helps to
carry out the exposure. VR allows a high level of control by
both the therapist and the patient, offering the possibility for
a very accurate gradation of the exposure tasks and making
it possible to design the virtual exposure treatment to fit each
patient’s needs. The context generated by the computer offers a
protected environment where the person can cautiously face the
feared situation at his/her own pace and speed. Therefore, VR
can be a key intermediate step between the therapist’s consulting
room, which is completely protected, and the threatening
real environment. VR allows the feared environments to be
customized according to the needs and preferences of users, who
can repeat the exposure several times until the fears are overcome.
Moreover, the feared situation is not always easily accessible (e.g.,
a cave, a tunnel). In these cases, imagery exposure is usually
used, but this technique is less effective than in vivo exposure,
and there are individual differences in imaginative ability (Botella
et al., 1998). VR provides more realistic stimuli for people who
have trouble imagining. Furthermore, VR makes it possible to
go beyond reality and create situations or elements that are so
threatening that they are not likely to occur in real life (e.g.,
in the virtual world we have developed for claustrophobia, a
wall can move forward, making a loud noise and leaving the
patient enclosed in a small space). Finally, VR is useful from an
ethical point of view; it protects the patient’s privacy and intimacy
because it is not necessary to leave the office to perform the
exposure tasks.
Despite these advantages, there are also some problems and
barriers associated with the use of VR. According to Riva (2005),
these barriers include the lack of standardized clinical protocols
for applying VR shared by the scientific community; the final
costs of the programs, although these costs actually decrease
dramatically from year to year; or ethical and security issues
regarding to possible side effects (Durlach and Mayor, 1995; Riva,
2005). However, it is also true that most people who use VR
systems either do not manifest any problem associated with the
use of this technology, or they experience mild and transient
symptoms such as dizziness and discomfort (Nichols and Patel,
2002). Finally, there are other barriers that impede the use of VR
in everyday clinical practice. On the one hand, some clinicians
find it difficult to accept the use of technologies because they feel
threatened and nervous about working with them. On the other
hand, some clinicians are reticent about the effect the use of these
technologies may have on the therapeutic relationship, although
studies have shown that this is not a problem (Andersson, 2009;
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Wrzesien et al., 2012, 2013). In this regard, it should be noted that
the purpose of VR and other applications based on technological
advances is simply to improve the treatment, and not to make
the therapist’s work superfluous or less meaningful. One study
(Segal et al., 2011) analyzed therapists’ perceptions of the benefits
and associated costs of the use of VR in the field of psychological
treatments. A sample of 271 professionals completed an online
survey, and the results indicated that overall they perceived
that the potential benefits significantly exceeded the potential
costs. However, this study only provides information about the
therapists’ intentions to use or not use VR because the therapists
did not actually use VR. In addition, data were obtained from
a set of pre-selected items, and no information was offered
about therapists’ opinions about positive and negative issues
from their real experience using VR. In fact, only 3% of the
therapists who participated in the study had experience in the
current use of this technology when applying psychological
treatments.
In sum, VR has been shown to be an effective technique
that can be useful to reduce the percentages of patients’ and
therapists’ rejection of the exposure technique. For this reason,
it is necessary to study the opinions of the “users,” both
therapists and patients, about the different ways of applying this
exposure technique, and find out to what extent they think tools
like VR enhance or complement traditional treatments, further
complicate the treatment, or can even be a disturbing element in
the therapeutic process.
Our group has developed a VR system called “EMMA’s World”
a VR system specifically designed for the treatment of PTSD,
CG, and AD to facilitate emotional change in people who have
suffered traumatic or stressful experiences (see Rey et al., 2005;
Botella et al., 2006, for a more detailed description). In EMMA’s
World patients can explore traumatic or stressful experiences to
the degree required for specific therapeutic needs. The system
shows customized, clinically significant environments for each
patient, emphasizing the meaning of the trauma or stressful
event over the realism of the VR environment. The efficacy
of this system has been shown in treating SRD, and these
results were maintained at follow-ups (Baños et al., 2009; Botella
et al., 2010). Furthermore, it has been compared to traditional
treatments (Baños et al., 2011), revealing that both treatment
programs (traditional and VR) were effective for these problems.
However, when differences were found between them, they
favored the protocol supported by EMMA’s World, especially
when the results are considered in the medium term (6-month
follow-up). In sum, EMMA’s World has been shown to be
an effective and versatile device. However, regardless of the
efficacy data, the literature suggests that there may be differences
between treatments preferred by therapists and those preferred
by patients. Thus, further research is needed to better understand
their attitudes and opinions about exposure therapy and help to
explain the underutilization of this treatment in clinical practice
(Becker et al., 2007).
The objective of this study is to analyze patients’ and therapists’
opinions about EMMA’s World, used as an adjunct tool to
improve the efficiency (understood as acceptability) of evidence-
based psychological treatment protocols for the treatment of
SRD. We will explore the opinions of patients and therapists
about the potential benefits and drawbacks of using (or not)
EMMA’s World. In other words, the purpose is to find out
their views about the psychological treatment they received
(patients) or applied (therapists) following a traditional format,
or supported by EMMA’s World. We want to discover whether
EMMA’s World has been useful or has, in some way disturbed
the process of change, and what aspects of this system could
be improved. Based on the literature on using VR for other
psychological problems (Botella et al., 2007; Baños et al., 2009;
McCann et al., 2014; Freeman et al., 2017), we expect the VR
system to be considered useful for therapy and well-accepted by
both patients and therapists.
MATERIALS AND METHODS
Participants
The study sample consisted of two groups. The first group
was composed of “professionals” (n = 10), clinical psychologists
who applied the treatment in a traditional format (“traditional”
condition) and the same treatment protocol using the VR
system (“EMMA” condition; see description below). All the
professionals had been applying cognitive behavioral therapy for
SRD in clinical practice for more than 7 years. All of them
had at least a master’s degree in clinical psychology, and the
majority had a Ph.D. They all worked at the PREVI Clinical
Psychology Center or at the Emotional Disorders Clinic at
Jaume I University (Spain). The treatment protocols had been
manualized to ensure their homogeneity, and a senior clinician
supervised the application of the treatments. Moreover, all the
professionals were experts in the use of technology, specifically
VR, for delivering psychological treatments.
The second group was composed of a convenience sample
of patients (n = 50), who met the criteria for at least one of
three different diagnoses according to the DSM-IV (American
Psychiatric Association [APA], 1994): PTSD (n = 15), CG
(n = 15), or AD (n = 20). They had participated in two previous
studies conducted by our team comparing the efficacy of the same
psychological treatment protocol with and without EMMA’S
World (two doctoral dissertations: Andreu-Mateu, 2011; N = 46
and Guillén, 2008; N = 39). In these two studies, the same
method of randomization was used. Participants were randomly
assigned to one of the two treatment conditions: “traditional
condition” and “EMMA condition” using a computer-generated
random number sequence. The Epidat 4.1 program was used to
generate this sequence. Randomization was stratified by primary
diagnosis. Block randomization was performed within each
stratum in order to ensure all primary diagnoses were equally
represented in both experimental conditions. The allocation was
carried out by an independent person who was not involved in the
study. The allocation sequence was concealed until interventions
were assigned. These two studies have been approved by the
Ethical Committee of Jaume I University.
The inclusion criteria for all the cases were: (1) meeting the
criteria for one of the three diagnoses (PTSD, CG, or AD);
age (2) between 18 and 65 years; and (3) in the case of taking
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medication, not increasing the dose or changing the medication
during the study; (4) and not being presently involved in
other psychological treatment. The exclusion criteria were: (1) a
diagnosis of psychosis diagnosis or severe personality disorder;
(2) suffering from a severe and incapacitating physical illness;
(3) substance dependence or abuse; and (4) secondary gains
derived from the problem (e.g., work leave, work disability,
etc.). In the present study were included the participants who:
(1) had completed the treatment in the previous study and were
therefore able to give their opinion about the treatment received;
and (2) answered the evaluation questionnaires and gave their
opinion about the treatment received.
All participants signed the informed consent before starting
the treatment. Patients were treated at the PREVI Clinical
Psychology Center or the Emotional Disorders Clinic at Jaume I
University (Spain). In the latter case, they were recruited through
derivations from Mental Health Units and announcements
posted at Jaume I University, the University of Valencia, and the
Polytechnic University of Valencia. The announcements, offered
psychological treatment to overcome stressful and traumatic
events.
Measures
Clinician-Administered PTSD Scale (CAPS; Blake
et al., 1990, 1995)
This interview rates whether there have been traumatic events in
the person’s life and the symptomatology associated with these
events, and it makes it possible to establish the diagnosis of
PTSD according to the DSM-IV. The CAPS allows the evaluator
to make an overall assessment of the severity of the PTSD, the
improvement since the prior assessment, and the validity of the
responses. Different studies have shown that it has high reliability
(internal consistency and inter-rater reliability and convergent
validity (Blake et al., 1990, 1995; King et al., 1998). Results
have also been reported about the sensitivity of the treatment
(Thompson et al., 1995). The mean score on the CAPS in a
clinical sample was 45.9 (SD = 29.1) (Blanchard et al., 1996).
Inventory of Complicated Grief (ICG) (Prigerson et al.,
1995, 1999)
This inventory is composed of 19 items to be rated on a five-point
scale from 0 (“never”) to 4 (“always”). This instrument assesses
the level of the person’s adjustment to grief or its interference
in his or her life. Exploratory analyses of the inventory have
shown high internal consistency and test–retest reliability, as
well as high convergent and criterion validity. In addition, an
association has been found between the scores on the ICG and
the severity of depressive symptoms, along with other measures
of emotional distress. Therefore, it is an adequate instrument to
assess complicated grief (CG) symptoms (Prigerson et al., 1995,
1999).
Diagnostic Interview for Adjustment Disorders
It is a semi-structured interview developed by our research group
to assess AD, taking into account the data provided by the
scientific literature, the diagnostic criteria of the ICD-10 and the
DSM-IV-TR, and the SCID-IV interview (First et al., 2002). It
also includes a list of 28 symptoms related to AD whose presence
and severity can be rated on a Likert scale from 0 (“not at
all”) to 8 (“very serious”). It has been applied in other studies
(Andreu-Mateu, 2011; Andreu-Mateu et al., 2012).
‘Treatment Expectations Scale’ and ‘Treatment
Satisfaction Scale’
Are an adaptation of Borkovec and Nau’s (1972) instrument for
assessing the patients expectations before starting the treatment
(once it has been explained), and their opinion and satisfaction
about the treatment after finishing it. Each scale consists of five
items, rated from 0 (‘strongly disagree’) to 10 (‘strongly agree’),
covering different domains related to the treatment: logicalness,
credibility/satisfaction, success in reducing symptoms, usefulness
for the patient’s specific problem, usefulness for treating other
psychological problems, confidence in recommending it to other
people with the same problem, and unpleasantness/aversiveness.
The expectations scale is applied once the treatment rationale
has been explained in the second assessment session. Its aim
is to measure the participant’s subjective expectations about the
intervention. The satisfaction scale is administered when the
participant has received the treatment, and its aim is to assess
the patient’s opinion of the intervention. We have used this
instrument in previous studies (Botella et al., 2008, 2009, 2016).
Opinion Sheet on Treatment
Once the treatment was finished, both patients and therapists
were asked to freely indicate their opinions about the treatment
they had received (patients) or applied (therapists). They were
explicitly asked to assess to what extent the treatment had been
useful for them (or not) in achieving their therapeutic objectives.
No restrictions were placed on length, and so each participant was
free to write as much as he/she desired. Every patient could assess
the treatment received, whether it was the treatment protocol
following traditional therapy, or the same protocol supported
by VR EMMA’s World. In the case of the therapists, they were
asked to give their opinions about both application protocols. All
participants were also asked to indicate anything related to the
treatment received (or applied) that could be useful for future
improvements.
The Virtual Environment: EMMA’s World
The VR system called EMMA’s World was developed to achieve
two fundamental objectives in clinical practice: on the one
hand, to induce and amplify emotional states in patients;
and on the other hand, to provide a system of visual and
auditory representations of concepts, ideas, and memories that
are meaningful to the patient. Therefore, the objective of EMMA’s
World is to facilitate emotional change in people who have had
traumatic, disturbing, and stressful experiences. The patient can
visualize a virtual environment where a series of tools can be
selected by the patient and the therapist. A series of emotional
virtual objects and environments can be used and personalized so
that they are meaningful to the patient. The objective is to obtain
a physical representation of the personal meanings and emotions
related to different patients’ problematic situations.
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Scenarios, Special Effects, and Book of Life
The system includes five different pre-defined scenarios designed
to reflect different emotions: a desert for anger, an island for
relaxation, a threatening forest for anxiety, a snow-covered town
for sadness, and a meadow for joy. In addition to making
complete modifications in the virtual environment, the therapist
and patient can graduate its intensity. Several special effects
can be controlled: rainbow, rain, snow, storm, etc.; and it is
also possible to modify the time of day (and its corresponding
lighting), the music, and the sound. The patients can also select
various symbols through a series of objects, videos, colors,
and images. The Book of Life is another important tool in
the system. In this book, the person can reflect on his or
her emotional experience (with words, images, objects, music,
etc.). All these elements are designed to activate and recall the
traumatic or stressful events in order to achieve their emotional
processing.
Control Interface
The therapist has a control interface that allows him or her to
prepare in advance the elements that will be used in a specific
session with a specific patient, and the therapist can also make
changes in EMMA’s World in real time during the session. At
each moment in the treatment, the therapist decides in which
scenario to place the patient, depending on the emotion worked
on in each session. These tools are not only used to help to induce
a particular emotion, but also as a reflection of the emotions the
patient may experience at any time during the therapy. Thus,
the scenario and its different modulators can be adapted to the
patient’s emotions at each point in the process, and the virtual
environment ca be used to try to increase empathy with the
patients. More detailed descriptions can be found in Rey et al.
(2005), Botella et al. (2006), and Baños et al. (2009, 2011).
Software and Hardware
The following devices are necessary for the use EMMA’s World:
two PCs[1], a large screen where the scenario is projected (5 mm
thick, on an aluminum base measuring 2.50 × 1.80 metros), two
projectors (SVGA Video projector, 1500 lumens), a wireless pad
and a speakers system (Speakers 2.1. 40W). These devices were
placed in a conditioned room to minimize the light in the room
and achieve greater immersion in the system. One of the PCs is
used to run the software, and the other PC is used by the therapist
to make the changes in the virtual environment in real time,
through a simple user interface. The software used to develop the
application is Brainstorm eStudio. The PC that runs the virtual
environment software has a graphic card with two connections;
one of them is connected to a video projector that is used to
project the image onto a methacrylate screen placed in the middle
of the room. A wireless pad is placed on the other side of the
room, and the patient can use it to interact and navigate in the
virtual environment. The sound system includes several speakers
distributed in the room.
Treatment Protocols
In the case of the “traditional” condition, the treatment protocol
was chosen that had the most empirical support for each of
the three disorders. In the case of the “EMMA” condition, the
same treatments protocols were adapted for application with the
support of the VR system. Each treatment protocol is described
below.
Post-traumatic Stress Disorder
In the case of PTSD, the “traditional” condition was based
on the Foa and Rothbaum intervention (Foa and Kozak,
1986; Foa and Rothbaum, 1998), which included the following
components: education, imaginal exposure, in vivo exposure,
cognitive restructuring and strategies to cope with anxiety,
such as breathing training, and finally, relapse prevention.
Basic training in acceptance strategies was also added. In the
EMMA condition, the same components were used, and the
only difference was that the imaginal exposure was applied
using VR.
Complicated Grief
The treatment protocol for the traditional component was
created by our group partly following the guidelines and
strategies recommended by Neimeyer (2000) and Neimeyer et al.
(2002). It includes the following components: education, the
Book of Life, restructuring the meaning of the loss, imaginal
exposure, in vivo exposure, coping strategies to manage anxiety
(such as slow breathing training), and relapse prevention. In
addition, it includes a series of techniques for acceptance of
loss, such as metaphors, a letter projecting into the future, etc.
The only difference between the two conditions was that in the
EMMA condition, the restructuring of the meaning was applied
using the electronic version of the Book of Life. The EMMA
condition is based on the same treatment protocol, but using new
technologies.
Adjustment Disorders
The treatment protocol includes the following components:
education, acceptance and elaboration of the negative events, and
relapse prevention (Becker et al., 2007). It also includes positive
psychology strategies that attempt to increase the human beings’
natural ability to resist adversity and use it to grow (Duckworth
et al., 2005). Exercises are used to extract positive aspects of the
situation experienced (Neimeyer, 2000; Neimeyer et al., 2002)
and train the patient in coping with problems. However, D’Zurilla
and Goldfried’s (1971) approach based on dimensions is not
followed because the aim is for the patient to view the problems
as necessary for growth and progress, and so Popper’s (1995)
approach is used. The psychological treatment components were
the same in both conditions, and the only difference was that the
imaginal exposure was applied with VR support.
Procedure
Individuals who showed interest in the treatment were
interviewed to establish whether they met the inclusion and
exclusion criteria. During this interview, the assessment and
psychological treatment protocol was explained to the patients
(psychological components included in the clinical protocol,
number of sessions, number of assessment points, etc.), and they
were told that this was a clinical trial with two experimental
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conditions, that both conditions were considered effective and
that there was no risk identified in either of them. Once the
patients agreed to participate in the study and signed the
informed consent, all the patients were randomly assigned to one
of the two experimental conditions: the “traditional condition”
(n = 25) and the “EMMA condition” (n = 25) following the
procedure explained above. After randomization, in the first
therapy session the patients were informed what condition they
had been assigned to.
The clinical assessment protocol was completed in two
sessions before the treatment, and the same assessment protocol
was applied again after the treatment.
The PTSD and CG treatment lasted approximately 9 weeks
with one session per week (3 for the educational component, 5 for
imaginal exposure/restructuring of the meaning of the loss, and 1
for relapse prevention). The AD treatment lasted approximately
6 weeks, with one session per week (1 for the educational
component, 4 for exposure, and 1 for relapse prevention). Each
exposure therapy session took approximately one and a half or
2 h. In all cases, for ethical reasons, people who needed it could
extend the treatment for 3 weeks in the case of PTSD and CG, and
2 weeks for AD, until accomplishing all the behavioral objectives
of the treatment.
Before starting the treatment, its rationale was explained
in detail to the patients, and they filled out the “Treatment
Expectations Scale.” Once they had finished the treatment,
patients filled out the ‘Treatment Satisfaction Scale’ and the
“Opinion Sheet on Treatment.” In the case of the therapists,
they were asked for their opinion about both treatments
(“EMMA condition” and “traditional condition”) on two
different “Opinion Sheets on Treatment.’
Data Analysis
A mixed-methods approach using quantitative and qualitative
methodologies was followed by the quantitative analyses were
organized in two phases. First, t-statistics for testing the pre-
test–post-test mean change were conducted separately for each
treatment group, taking the six individual items of the satisfaction
scale as the dependent variables, as well as the total score
of the scale. Assuming a nominal significance level of 5%,
probabilities were corrected following the Bonferroni method, so
that statistical significance was reached only when the p-value
was lower than 0.05/7 = 0.007. In addition, standardized pre-
test–post-test mean change effect sizes (d) were calculated for
each dependent variable, and a 95% confidence interval was
calculated (Morris, 2008). Following Cohen (1988) d indices of
about 0.5 and 0.8 were interpreted as indicating a moderate and
large clinical magnitude, respectively. In a second phase, for each
dependent variable a mixed ANOVA was applied, taking the
treatment (Traditional vs. EMMA) as between-groups factor and
the measurement occasion (pre-trial vs. post-trial) as the within-
group one. Bonferroni adjustment was also applied in these
ANOVAs. The F-test for the treatment x occasion interaction
was complemented by calculating standardized pre-test–post-test
mean change indices between the two groups for each dependent
variable (dchange), as well as a 95% confidence interval (Morris,
2008). The same Cohen’s (1988) guidelines were also applied to
these effect sizes. All statistical analyses were carried out with
SPSS 24.0.
Moreover, a qualitative methodology was applied following
the principles of the Consensual Qualitative Research (CQR)
approach (Hill et al., 1997, 2005; Hill, 2012). This qualitative tool
is based on Grounded Theory (Glaser and Strauss, 1967), but
specifically developed for clinical content. CQR involves asking
the participants specific open-ended questions about a topic.
Their responses are then coded into themes in a consensual
manner by a group of researchers. The essential components
of CQR (Hill et al., 2005) are the use of: (a) open-ended
questions in semi-structured data collection techniques -usually
in interviews-; (b) different judges throughout the data analysis
process to provide multiple perspectives; (c) consensus strategies
to arrive at judgments about the meaning of the data; (d) at least
one auditor to check the work of the primary team, trying to
minimize bias or the effects of groupthink; and (e) the generation
of domains, core ideas, and cross-analyses in the data analysis.
The three steps for conducting CQR are developing and coding
domains, constructing core ideas, and developing categories to
describe consistencies across cases (cross analysis). Consensus is a
key part of the CQR method, which “relies on mutual respect,
equal involvement, and shared power” (Hill et al., 1997). In this
study, we use an adaptation of the CQR approach because we did
not use interviews, but rather in-depth analysis of texts written by
the participants to express their opinions about the treatments.
Following the CQR guidelines, we had a primary team and an
auditor, and in order to reach consensus, all the team members
discussed disagreements and feelings at each step in the process.
The primary team was composed of two members (one Master’s
degree student and one Ph.D. student). The audit was performed
by a third researcher (a Ph.D. student). First, the domains were
established. The next step was the analysis of the core ideas,
which were classified in the existing domains. Finally, a cross-
analysis was carried out to establish the transversal categories.
Each step was performed independently by the two researchers
on the primary team. The auditor resolved the discrepancies
at each step, except in the cross-analysis for the categories,
which was independently carried out by the auditor. Once
his/her categories had been generated, the auditor contrasted
them with those generated by the primary team. The whole
procedure was monitored by a Ph.D. full professor in clinical
psychology.
RESULTS
The mean age of the sample was 31.28 years old (SD: 8.69) and
ranged from 18 to 50 years. Most of the sample (70.0%) were
female, and the remaining 30.0% were male; 60% single, 24%
married, 2% widowers, and 14% divorced. With regard to the
education level, 16% had an elementary level; 28% had a high
school education level, and 56% had a university degree. Most
of the sample (92%) did not have another Axis I diagnosis, and
the rest (8%) did. Regarding other Axis II diagnoses, most of the
sample (88%) did not have another Axis II diagnosis, and the rest
(12%) presented Axis II co-morbidity.
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Patients’ Opinion: Quantitative Analysis
Table 1 presents the results of the t-test comparison of pre-
test–post-test means for the traditional therapy group. A first
inspection of the data reveals averages for all items above
seven points, including the total scale score, except for the item
‘unpleasantness’ in the pre-test, which is lower (mean = 5.81).
A second result worthy of mention is that, in all items, and in
the total score of the scale, higher means are observed in the
post-test than in the pre-test, which indicates an improvement
in the evaluation of the treatment by the patients. Thirdly, it is
observed that, assuming a level of significance of 5%, statistically
significant improvements were observed in items 2 and 3 and in
the total score. However, if we apply the Bonferroni correction,
none of these t-tests reaches statistical significance (p > 0.007).
Fourth, and despite not achieving statistically significant results
according to the Bonferroni correction, effect sizes, in terms of
standardized mean change, are observed that can be considered
clinically relevant according to the Cohen (1988) criterion for
item 3 (recommend to others, d = 0.51), item 2 (d = 0.48) and
for the total score (d = 0.46).
Table 2 presents the results of the t-test comparison of pre-
test–post-test means for the EMMA therapy group. The data
reveals averages for all items above 7.5 points, including the total
scale score, except for the item ‘unpleasantness’ in the pre-test
(mean = 5.91) and in the post-test (mean = 6.78). A second result
worthy of mention is that, in all items, and in the total score
of the scale, higher means are observed in the post-test than in
the pre-test, which indicates an improvement in the evaluation
of the treatment by the patients. Thirdly, it is observed that,
assuming a level of significance of 5%, statistically significant
improvements were observed in items 2, 3, 4 and 5, and in the
total score. However, if we apply the Bonferroni correction, only
item 3 (recommend to others, p = 0.002) and the total scale score
(p = 0.002) reach statistical significance (p < 0.007). Fourth, we
observe effect sizes, in terms of standardized mean change, that
can be considered clinically very relevant according to Cohen’s
(1988) criteria for the total score (d = 0.72), item 3 (recommend
to others, d = 0.70), item 5 (usefulness for the patient, d = 0.50)
and item 4 (usefulness for others, d = 0.47).
Table 3 presents the results of the mixed ANOVAs applied to
the treatment condition (intergroup factor) and to the occasion of
measurement (intra-group factor), taking as dependent variables
the items and the total score of the scale. No statistically
significant differences were observed between the two treatments.
Statistically significant differences were observed for the average
occasion in all items and in the total score, with the exception of
item 1. However, applying the Bonferroni correction, only items
2 (p = 0.003) and 3 (recommend to others, p < 0.001) and the
total score (p = 0.001) reached statistical significance (p< 0.007).
Finally, and as a more relevant result, no significant effects of
the interaction between the treatment and the measurement
occasion were observed, indicating that the changes from pre-
test to post-test were similar in the two treatments. In relation
to the interaction, however, it is worth noting the obtaining of
moderate-low magnitude effect sizes with items 4 (usefulness
for other disorders, dchange = 0.31) and 5 (usefulness for other
TABLE 1 | Results of t-tests and effect sizes comparing expectation (pre-trial) and satisfaction (post-trial) of the patients in the traditional group.
Statement Pre-trial M (SD) Post-trial M (SD) t p d (95%CI)
(1) Treatment logic 7.95 (1.91) 8.43 (1.16) 1.19 0.248 0.25 (−0.19, 0.69)
(2) Treatment satisfaction 7.76 (2.00) 8.86 (1.42) 2.29 0.033 0.48 (0.02, 0.94)
(3) Recommending to others 7.95 (1.96) 8.90 (1.37) 2.42 0.025 0.51 (0.04, 0.98)
(4) Usefulness for other disorders 7.57 (2.38) 7.95 (1.53) 0.77 0.451 0.16 (−0.28, 0.60)
(5) Usefulness for the patient 8.19 (1.99) 8.71 (1.42) 1.02 0.321 0.21 (−0.23, 0.65)
(6) Unpleasantness∗ 5.81 (3.33) 7.14 (2.63) 1.68 0.109 0.35 (−0.10, 0.92)
Total score 7.54 (1.67) 8.33 (1.24) 2.18 0.041 0.46 (0.00, 0.92)
M = mean. SD = standard deviation. t = t-test comparing the means for expectations (pre-trial) and satisfaction (post-trial); positive t-values indicated a larger mean in
the post-trial than in the pre-trial. p = probability level associated to the t-test. d = standardized mean change effect size. 95%CI: 95% confidence limits for d. ∗ Item 6 is
answered in reverse, and so it has been recoded to follow the same scoring criteria as the other five items on the scale.
TABLE 2 | Results of t-tests and effect sizes comparing expectation (pre-trial) and satisfaction (post-trial) of the patients in the EMMA group.
Statement Pre-trial M (SD) Post-trial M (SD) t p d (95%CI)
(1) Treatment logic 8.39 (0.84) 8.70 (1.15) 1.19 0.245 0.24 (−0.18, 0.66)
(2) Treatment satisfaction 8.17 (1.70) 8.78 (1.20) 2.13 0.045 0.43 (−0.01, 0.87)
(3) Recommending to others 8.35 (1.43) 9.13 (1.10) 3.46 0.002 0.70 (0.23, 1.17)
(4) Usefulness for other disorders 7.83 (1.82) 8.70 (1.26) 2.33 0.030 0.47 (0.03, 0.91)
(5) Usefulness for the patient 8.04 (1.92) 8.78 (1.31) 2.49 0.021 0.50 (0.06, 0.94)
(6) Unpleasantness∗ 5.91 (3.36) 6.78 (2.88) 1.17 0.255 0.24 (−0.18, 0.66)
Total score 7.78 (1.37) 8.48 (1.01) 3.58 0.002 0.72 (0.25, 1.19)
M = mean. SD = standard deviation. t = t-test comparing the means for expectations (pre-trial) and satisfaction (post-trial); positive t-values indicated a larger mean in
the post-trial than in the pre-trial. p = probability level associated to the t-test. d = standardized mean change effect size. 95%CI: 95% confidence limits for d. ∗ Item 6 is
answered in reverse, and so it has been recoded to follow the same scoring criteria as the other five items on the scale.
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TABLE 3 | Results of the mixed ANOVAs taking treatment and occasion as inter-groups and within-group factors.
Statement Treatment Occasion Interaction dchange (95%CI)
F p F p F p
(1) Treatment logic 1.22 0.276 2.81 0.101 0.14 0.714 −0.01 (−0.62, 0.60)
(2) Treatment satisfaction 0.18 0.675 9.75 0.003 0.79 0.378 −0.05 (−0.68, 0.58)
(3) Recommending to others 0.63 0.432 15.27 <0.001 0.15 0.704 0.19 (−0.47, 0.85)
(4) Usefulness for other disorders 1.26 0.267 4.15 0.048 0.63 0.430 0.31 (−0.31, 0.93)
(5) Usefulness for the patient 0.01 0.925 4.72 0.035 0.14 0.713 0.29 (−0.33, 0.91)
(6) Unpleasantness∗ 0.03 0.865 4.10 0.049 0.18 0.672 −0.11 (−0.72, 0.50)
Total score 0.31 0.583 13.68 0.001 0.06 0.809 0.26 (−0.40, 0.92)
F = F statistic for testing the significance of the treatment, the occasion, and the treatment × occasion interaction; all F-tests had 1 and 42 degrees of freedom.
p = probability level associated to the F-test. dchange = standardized mean change between the two treatments (positive dchange values indicated a larger increase from
expectations to satisfaction in EMMA than in TAU). 95%CI: 95% confidence limits for dchange. ∗ Item 6 is answered in reverse, and so it has been recoded to follow the
same scoring criteria as the other five items on the scale.
patients, dchange = 0.29) and with the total score (dchange = 0.26).
The positive sign of these three effect size indices indicates a more
pronounced pre-test–post-test change in the EMMA therapy
group than in the traditional group.
It should also be noted that mixed ANCOVAs were used to
control the possible influence of covariates such as the degree
of interference (pre-test and post-test), the consumption of
medication and the history of the disorder, and that the results
remained unchanged.
Patients’ Opinion: Qualitative Analysis
This section presents the patients’ answers to the “Opinion Sheet
on Treatment” after the intervention. Tables 4, 5 show the
domains, categories, and core ideas obtained from the patients’
opinion about the traditional and EMMA treatment conditions,
respectively.
Traditional Treatment
Regarding traditional treatment, only two domains were found
(“Perception of change after treatment” and “Type of change”). It
must be noted that all the patients had the opportunity to write
whatever they wished about the treatment they received on an
observation sheet.
TABLE 4 | Patient’s traditional condition.
Domains Categories Core ideas
- Perception of
change after
treatment
Positive change
perceived (general)
“It was a very useful treatment
for me. I am very grateful for
everything”
- Type of change Emotional change
- Anxiety management
(typical)
- Cognitive change
(variant)
Coping
- Relief (typical)
- Resilience (typical)
“It helped me to manage the
anxiety better, especially my
pulse”
Patient states that the
treatment helped him in the
way he thought
Patient says she could talk
normally about the issue with
her grandmother
“Overcome the problem helped
me to feel very proud of myself”
In the domain “Perception of change after treatment,” all
the patients’ comments were classified under the category
“Positive change perceived.” In the domain “Type of change,”
three categories were identified: “Emotional change” (typical),
“Cognitive change” (variant) and “Coping,” which has two
subcategories (“Relief” and “Resilience”). Based on the patient’s
comments, it can be hypothesized that “Relief” is more typical
of PTSD, as people start to feel like they did before the stressor,
whereas “Resilience” is more present in cases of AD, where the
patients easily feel that the situation was an opportunity for
personal growth.
EMMA Treatment
Regarding the EMMA treatment, and in contrast to the
traditional condition, more domains were identified because the
comments made by the patients were richer and more developed,
leading to the identification of four domains “Perception of
change after treatment,” “Type of change,” “Perceptions about the
treatment,” and “Strategies to improve the treatment.”
The domain “Perception of change” was identified in all cases,
which can be understood based on the success of the treatment
delivery. The domain “Type of change” reflected the wide variety
of changes that patients experienced, and they were classified
in four categories: Emotional change (Anxiety management
and Acceptance), Cognitive change, Coping (Resilience and
Relief), and Other (including aspects such as sleeping better or
improvements in interpersonal relationships).
The domain “Perception of the treatment” included
three categories: “Re-experiencing the experience” (typical),
“Emotional processing” (typical), and “Treatment elements
particularly useful to them.” Finally, the last domain was
“Strategies to improve the treatment,” which included two
categories: “Usability aspects” (rare) and “New functionalities”
(variant).
A few difficulties are described in the EMMA condition,
but they do not include the necessary information to establish
a domain with categories. An example is: “Sometimes I had
difficulties in choosing the symbols; I would have liked it to
be more personalized: images in real environments, instead of
animated graphics.”
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Therapists’ Opinion: Qualitative Analysis
In this section, the therapists’ answers to the “Opinion Sheet on
Treatment” about the two intervention protocols are analyzed.
Tables 6, 7 show the domains, categories, and core ideas obtained
from the therapists’ opinions about the traditional and EMMA
treatment conditions, respectively.
Traditional Treatment
Regarding the traditional treatment, three domains were
identified: the “Perception of change after treatment,” “Treatment
features that have hindered,” and “Treatment features that have
helped them.” In the “Perception of change after treatment,” the
only category that appeared in the analysis was “Positive change
perceived.” This can be attributed to two aspects: on the one hand,
the therapists were only asked to focus their comments on the
treatments (protocols). On the other hand, the absence of other
categories does not imply their inexistence because it is due to
the small amount of information available for analysis. In this
direction, all the answers in this domain about the perception
of change after treatment were categorized as “Positive change
perceived.”
In the “Treatment features that have hindered,” some negative
comments are included. However, it must be noted that all
the therapists took part in both conditions. Therefore, their
answers tend to involve a comparison of the EMMA and the
traditional conditions. Hence, the negative comments should
not be considered intrinsically negative, but as comparisons
to the EMMA condition. The therapists put special emphasis
TABLE 5 | Patients: EMMA condition.
Domains Categories Core ideas
- Perception of change after
treatment
Positive change perceived (general) Patients say the treatment was very useful
- Type of change Emotional change
- Anxiety management (typical)
- Acceptability (variant)
Coping
- Resilience (typical)
- Relief (this category involves everything that means
going back to the state before the stressful event,
whereas the other category in fact increases after the
stressor)
Cognitive change (typical)
Others (rare)
Patient states that she is less restless
Patient states that she can express her emotions about the
event without judging them
Patient could fully cope with life
Patient states that she is finally able to wipe him husband
out of her mind
Patient says a heavy load has been lifted
Not as many memories come to my mind like before, and
images come and go; they do not hurt; I’m not scared
about keeping those images in my mind
Improvements in sleeping
- Perceptions about the treatment
(protocol)
- Re-experiencing the experience through the virtual
system (typical)
- Emotional processing (typical)
- Treatment elements that have particularly helped them
(typical)
Photographs helped me to place myself in the event and
relive the accident
“I found it easier to express emotions with the help of virtual
environments and the devices that were included in the
system”
Patient stated that the photographs helped him to
re-experience the situation
Strategies to improve the treatment - New functionalities or evolutions of the system (variant)
Usability aspects (rare)
Patient stated that it would be better to handle the system
in an easier way
Patient mentions that there should be more symbols
TABLE 6 | Therapists: traditional condition.
Domains Categories Core ideas
- Perception of change after treatment Positive change perceived (general) Therapists say the treatment was very useful
- Treatment features that have hindered
the therapy process
- Therapeutic techniques (variant)
- Emotional processing (typical)
- Specific elements (rare)
Therapists state that exposition in vivo is sometimes difficult to carry out
Therapists say that there are patients that have difficulties in imagining the
diverse situations
Therapists state that exposure in imagination presents some problems, the
application of this technique was quite hard to accomplish
Therapists state that ideas expressed in words sometimes are not as
intensely and realistically remembered as when using images
-Treatment features that have helped
them
- Acceptability of the patients (typical)
- Techniques/treatment components
(variant)
- Manualization of the treatments (rare)
Therapists state that patients feel understood and accept the treatment
Therapists say that exposure in imagination and in vivo are very powerful
and effective
Therapists mention that having manualized treatment protocols makes it
much easier when programming the sessions
They are brief treatment protocols where an improvement is perceived from
the very first sessions
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TABLE 7 | Therapists: EMMA condition.
Domains Categories Core ideas
- Perception of change after treatment Positive change perceived (general) Therapists say the treatment is a very useful treatment for patients
- Treatment features that have helped
them
- Emotional processing (general)
- Re-experiencing the experience through
the virtual system (typical)
- Specific elements or resources of the
virtual system that have helped (variant)
- Acceptability of the treatment (variant)
Therapists say that the use of symbols facilitates emotional expression
Therapists express that, although re-experiencing can be painful, the system
helped them to go through it
Therapists state that using pictures and music selected by the patient has a
powerful effect on the treatment
Therapists say the system provides a safe environment
- Strategies - Usability (variant)
- Technical features/resources (variant)
Therapists state that the system should improve the ease of use of the
treatment
Therapists mention that it would be a good idea to incorporate the emotion
thermometer in the system
on the difficulty of “Emotional processing” in the traditional
treatment. It has been classified as a typical category following
the CQR principles. In this regard, it is quite linked to the
category (variant) of “Therapeutic techniques,” which refers
to therapists’ comments about the difficulties in applying
techniques such as in vivo exposure and exposure in imagination.
In addition, the category “Specific elements” (which is a
rare category) highlights the scant use of elements such as
symbols or metaphors. Therefore, the presence of all these
categories may explain the potential of a virtual system like
EMMA (this is developed in the EMMA condition analysis),
which can deal with some aspects considered negative by the
therapists.
In the “Treatment features that helped,” although many
obstacles and barriers were described by the therapists, there
is still a generally positive view of the protocol, as stated in
the first domain. One of the aspects mentioned was the way
the therapists thought the patients would accept the treatment.
In this case, the category “Acceptability of the treatment” was
classified as a variant, including aspects such as the flexibility of
the manualization of the treatments.
EMMA Treatment
In the EMMA condition, three domains were identified:
“Perceptions of change after treatment,” “Treatment features that
helped,” and “Strategies.”
In “Perceptions of change after treatment,” all the therapists
reported a positive change in the patients after the treatment,
leading to one single general category called “Positive change
perceived,” as in the traditional condition. Therefore, the most
interesting aspect lies in the differences in the specific processes
the therapists said were helpful (particularly because all the
therapists took part in both conditions, and their answers took
their comparisons into consideration).
In the domain “Treatment features that helped,” and as
in the traditional condition, the overall perception of change
is also generally positive. Here, the “Emotional processing,”
category, which is classified as general, is expressed as a
particular positive aspect to be highlighted in the VR system.
All the therapists except one emphasized the importance of
“Emotional processing.” Likewise, the category “Re-experiencing
the experience through the virtual system” (typical) was another
important aspect described by the therapists that explains how
the VR system can be better than the traditional treatment.
Indeed, another category was identified that focuses on aspects
the therapists described as improved in the EMMA’s World
condition compared to the traditional treatment. Additionally, a
variant category is called “Specific elements or resources of the
virtual reality system that have helped,” such as “The book of life.”
Last, but not least, there was a category called “Acceptability of
the treatment,” which is coherent with the rest of the identified
categories because it emphasizes that the VR system provides a
safe environment.
There were also some negative features identified, but these
aspects were not sufficient to build categories, due to the scarcity
of the data collected. On this point, it must be noted that all the
participants (both patients and therapists) were asked to answer
the open questions about the treatment, but not all of them did
so. Based on the data obtained, some of the potential categories
on the negative aspects could be: (a) Patients’ reluctance to
use the technology; (b) Rejection of the use of a VR system
by the therapist due to the extra work that might be involved.
Finally, in the domain “Strategies” to improve the system, there
are two main categories: “Usability” and “Technical aspects and
resources.” The therapists indicated that efforts were needed to
make the technology very simple to use.
DISCUSSION
The objective of this study was to explore the opinions of
patients and therapists about psychological treatment protocols
supported by VR. Specifically, the application called EMMA’s
World, a VR system designed for the treatment of stress-related
disorders (PTSD, CG, and AD), was used. In particular, this
study was aimed to analyze the usefulness of this VR system
in increasing the efficiency (known as acceptability) of the
psychological treatment protocols. Results indicate that EMMA’s
World is well-accepted by both patients and therapists.
The expectations patients expressed about the treatments were
very high in both conditions before starting the intervention,
and patients’ opinion scores significantly improved after the
treatment ended. No significant differences were found between
the two conditions. However, effect sizes indicated a more
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pronounced pre-test–post-test change in the EMMA therapy
group than in the traditional group.
The qualitative analysis showed that patients and therapists
in both conditions perceived the treatment to be useful and
efficacious. Nevertheless, the analysis of the patients in the
EMMA condition provided much richer content. The patients
perceived a positive change in general, identified a diverse range
of types of changes and elements that helped them, and indicated
that EMMA’s World strengthened motivation for the therapy
and helped them to process the negative or stressful event they
experienced throughout the treatment (“Photographs helped me
to place myself in the event and relive the accident”; The “Book
of life helped me to relive some good situations I experienced
with my father”; “The background sound of the sea made me
remember, and it helped me to bring to the surface feelings and
sensations that I held and did not even recognize”).
In the case of therapists, because they participated in both
conditions, the answers tended to be a comparison of the two
conditions. All the therapists made positive comments about the
usefulness of both treatments, but in the case of the traditional
condition, they were more focused on efficacy (i.e., “Imaginal and
in vivo exposure were very powerful tools that have been very
effective”; “I find the treatment useful and effective”), whereas in
the EMMA condition, the comments referred to how attractive
it is for the patient (i.e., “The simple use of new technologies
makes the treatment more attractive to the patient”; “The sessions
using VR become much more pleasant, the patient is highly
motivated, and the recovery is much faster”), emphasizing the
flexibility (i.e., “Each session can be done in a very different way
from the previous one, using other environments, other music,
other symbols, and this is very attractive”) and the possibility of
customizing it (i.e., “The possibility of customizing the scenario,
including meaningful photographs, music, etc. for the patient,
is very attractive”), in addition to helping the patients to better
express their problems and emotions (i.e., “The patients told me
that both the EMMA environment and the sounds or symbols
helped them to express things that would have been very difficult
to say in words”). Moreover, whereas some therapists identified
some features that may be hindrances in the traditional condition
(they recognized how difficult the imaginal technique was for
some patients, and how hard the exposure technique was for the
majority of them), they indicated that these limitations could be
reduced with EMMA’s World. All of them found many positive
features in the EMMA condition, especially in the exposure
techniques and emotional processing, indicating that the VR
system helped to foster motivation in patients while helping the
therapist to apply the treatment. However, they also indicated
that there is a need to improve the usability of the system (“I
think anything that can facilitate the usability and friendliness of
the system for patients should be improved, as well as the session
preparations and the course on the sessions for therapists”). In
conclusion, this analysis shows that VR can be a useful adjunct to
treatment.
These results support those obtained in previous studies
in this field. High rates of acceptance by the participants
using VR have been observed, in comparison with in vivo
exposure, for the treatment of phobias in subclinical populations
(García-Palacios et al., 2001) and clinical populations (Botella
et al., 2007; Quero et al., 2014). Similar results were obtained
in the treatment of panic disorder with or without agoraphobia
(Botella et al., 2007). In the case of the assessment and
treatment of pain, patients have also shown high acceptance of
the introduction of technology, and they have very positively
appraised the use of technologies, highlighting that these tools
could have a positive influence on the treatment outcomes
(Spyridonis et al., 2013). In the same way, preliminary data in
patients who suffer from stress-related disorders indicate high
levels of satisfaction with the use of VR (Baños et al., 2009;
Andreu-Mateu, 2011).
In this study, the fact that both patients and therapists rate the
use of the VR system in a positive way is clearly encouraging.
The incorporation of technology into the traditional treatment
protocol has not harmed the patients’ expectations or opinions
about it. Furthermore, in this study the treatment of choice was
used as the control group, that is, as the “gold standard” from
the perspective of the evidence-based treatment protocols (in
the case of PTSD), or alternative treatments that had higher
empirical support and were recommended in the specialized
literature in the case of CG and AD. Quantitative analysis results
indicate that the users’ (patients and therapists) assessment
of VR is similar to what was obtained for in vivo exposure
treatment, and qualitative analysis show that their opinions were
even more positive. Including this type of VR-based element to
assist the therapy could help to decrease the high percentage of
therapists who are reluctant to use an effective technique like
exposure.
This study has limitations. On the one hand, each patient
only gave an opinion of the treatment applied to him or her,
and so the opinion of a person who has first-hand information
about both treatments remains to be explored. Only the therapists
could assess both treatments because all of them delivered the
treatments in both experimental conditions. On the other hand,
the sample of therapists is small, and all of them received
training to work with the VR system, but it is still necessary to
explore the opinions of therapists who did not have any previous
knowledge about the use of these technologies. However, the
study by Segal et al. (2011) found that the therapists (N = 271)
perceived that the benefits of using VR significantly exceeded the
potential costs. In addition, the sample size of patients is not very
large, and so future research should include a larger number of
participants. Another limitation relates to the use of technology
itself. Although our clinic is renowned for applying evidence-
based psychological treatments, it is also well-known that some
treatments are supported using technology. Therefore, although
participants were invited to receive psychological treatment for
their problems, perhaps more patients came in who did not
reject the use of technology. Finally, it would also have been
desirable to have stricter control over participants’ adherence to
the treatment, but because the purpose of this study was to find
out the patients’ opinion about the treatment they had received,
only participants who finished the treatment in the previous
studies were included in the present study.
Despite the encouraging results obtained in this study, there
are still barriers to the routine use of VR in clinical practice
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(Riva, 2005; Segal et al., 2011). The first of these barriers refers to
the economic costs of these systems, although, thankfully, costs
have been declining rapidly in recent years, and progress is being
made to implement these VR programs over the Internet, and
even using smartphones. This, without a doubt, will simplify and
reduce the costs of these programs. The second barrier is related
to the possible technical difficulties that professional clinicians
could have when using these systems, and the possible need for
training to learn to use them. However, this topic always arises
when new advances are made in treatments because clinicians
have to be specifically trained to use them.
Many professionals are reluctant to introduce these tools in
their clinical practice, or they feel threatened by the use of
these technologies, perhaps because they do not understand the
range of possibilities that these technologies can offer them. This
problem is also linked to the lack of standardization in many of
the hardware devices and software. To date, few available systems
are interoperable, which makes it difficult to use them in different
contexts from those for which they were developed. However,
although this issue seems to be of great importance, it is gradually
being overcome because the use of these technologies is being
simplified as much as possible (user friendly systems), there are
now training programs to teach these new strategies, and the
advantages of these systems in clinicians’ daily work are clearly
being demonstrated through data and empirical evidence. The
expectation is that these types of systems will increasingly be
developed (Newman et al., 2011).
Another possible barrier is the lack of standardized protocols
shared by the scientific community, although this limitation is
being corrected, and there are already some published protocols
for the treatment of eating disorders (Riva et al., 2003), fear of
flying (Klein, 1999), panic disorder (Vincelli et al., 2001; Botella
et al., 2007), stress related disorders (Baños et al., 2009). Finally,
there are ethical and safety issues (Durlach and Mayor, 1995;
Botella et al., 2004). However, the data indicate that problems
associated with VR are not frequent, and if they do appear, they
are not serious, being limited to mild and transient discomfort
and/or dizziness (Nichols and Patel, 2002).
We agree with Riva (2005), Riva and Repetto (2014), and
Riva et al. (2015, 2016) that VR can become a substantial part
of Clinical Psychology. For this reason, it is essential for all
professionals to have a clear understanding of the opportunities
that VR and other tools based on ICTs can provide in professional
practice. To achieve this, on the one hand, it is necessary to carry
out a proper dissemination and communication of the results
that have already been obtained and, on the other, make progress
in designing devices that are friendlier and easier to use at an
affordable cost.
In sum, it seems that the use of technology in the field
of Clinical Psychology is no longer a possibility. These tools
have already shown their efficacy, and they are considered
very promising and helpful elements in delivering psychological
treatments (Clough and Casey, 2011; Turner and Casey, 2014;
Freeman et al., 2017). Studies such as this one show that these
tools are appreciated by users (both patients and therapists), and
now it is time to incorporate them into daily clinical practice and
show that they can be very useful for the variety of tasks that
professionals should perform in the field of Clinical Psychology.
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